STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

ProtoKinetix 8-K details Regulation FD stockholder update

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

ProtoKinetix, Incorporated furnished a company update to its stockholders. The update was distributed by the company and is included as Exhibit 99.1 to this report, where the full text can be read.

The information is provided under a Regulation FD disclosure, meaning it is intended to share information with all investors at the same time. The company specifies that this material is being furnished rather than filed, so it is not automatically incorporated into other securities law filings.

Positive

  • None.

Negative

  • None.
false 0001128189 0001128189 2025-11-21 2025-11-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: November 21, 2025

 

ProtoKinetix, Incorporated

(Exact name of registrant as specified in its charter)

         
Nevada   000-32917   94-3355026

State of Incorporation

 

Commission

File Number

 

IRS Employer

Identification Number

 

109 W Main Street,

Dalton, OH 44618

Address of principal executive offices

 

330-445-4971

Telephone number, including Area Code

 

_______________________________

 

 Former name or former address if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A        

 

 

 
 

 

 

Item 7.01. Regulation FD Disclosure.

 

On November 21, 2025, ProtoKinetix, Incorporated (the “Company”) sent out a Company update to its stockholders. The full text of the update referenced herein is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

 

The information in this Item 7.01 of the Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

  Exhibit
No.
  Description
  99.1  

Company update

  104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

  

 

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 21st day of November 2025.

  

ProtoKinetix, Inc.  
     
By:   /s/ Michael Guzzetta  
  

Michael Guzzetta, President, CEO & CFO

 

 

 

 

 

 

FAQ

What did ProtoKinetix (PKTX) disclose in this 8-K?

ProtoKinetix furnished a company update to its stockholders, identified as Exhibit 99.1, under a Regulation FD disclosure item.

Where can investors find the ProtoKinetix (PKTX) company update?

The full text of the company update is included as Exhibit 99.1 to this report and is incorporated by reference into the 8-K.

Is the ProtoKinetix (PKTX) company update considered filed with the SEC?

No. The company states the information in Item 7.01 and Exhibit 99.1 is furnished and not filed under the Exchange Act.

What is the purpose of ProtoKinetix (PKTX) using Item 7.01 Regulation FD Disclosure?

Item 7.01 allows ProtoKinetix to share its company update publicly so all investors receive the same information at the same time.

Does this ProtoKinetix (PKTX) 8-K include new financial statements?

No additional financial statements are listed; the main exhibit is the company update in Exhibit 99.1.
Protokinetix Inc

OTC:PKTX

PKTX Rankings

PKTX Latest News

PKTX Latest SEC Filings

PKTX Stock Data

2.65M
244.03M
37.92%
0.01%
Biotechnology
Healthcare
Link
United States
Dalton